DMARD Taper-to-Discontinuation Approach Increases Flare Risk
A study called ARCTIC REWIND found that patients with rheumatoid arthritis (RA) in remission who tapered or stopped their medication experienced more disease flares compared to those who stayed on stable doses. Patients taking only csDMARDs had higher flare rates than those on TNF inhibitors, but the risk was still elevated in both groups. The…